Brief: Lunit Received U.S. Food And Drug Administration (FDA) 510(K) Clearance
Nov 14 (Reuters) - Lunit Inc 328130.KQ :
* LUNIT INC: RECEIVED U.S. FOOD AND DRUG ADMINISTRATION
(FDA)
510(K) CLEARANCE FOR ITS 3D BREAST TOMOSYNTHESIS (DBT) AI
SOLUTION, LUNIT INSIGHT DBT
Source text for Eikon: ID:nPn41NYsMa
Further company coverage: 328130.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunit
See all newsBrief: Summit Therapeutics And Lunit Announce Agreement To Apply Ai-Powered Scope Io Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution